CD8A and neoplasm: As compared to mice receiving only anti-PD1 treatment, we observed that Trp2Vax and TA99-WT or TA99-HL2-KOA1 treatment appeared to increase frequencies of tumor-infiltrating macrophages, CD4+ and CD8+ T cells, while decreasing the frequencies of monocytes (Figure 3I).